FISPGHAN statement on the global public health impact of metabolic dysfunction-associated steatotic liver disease.
Mitsinikos T, Aw MM, Bandsma R, Godoy M, Ibrahim SH, Mann JP, Memon I, Mohan N, Mouane N, Porta G, Verduci E, Xanthakos S.
Mitsinikos T, et al. Among authors: ibrahim sh.
J Pediatr Gastroenterol Nutr. 2024 Dec 27. doi: 10.1002/jpn3.12399. Online ahead of print.
J Pediatr Gastroenterol Nutr. 2024.
PMID: 39727048
Review.